Maud D'Aveni-Piney, Claire Michel, Marie Robin, Stephane Morisset, Didier Blaise, Johan Maertens, Patrice Chevalier, Cristina Castilla-Llorente, Edouard Forcade, Patrice Ceballos, Ibrahim Yakoub-Agha, Xavier Poiré, Martin Carre,
Wen Wang, Xiao Zhang, Ning Zhao, Ze-Hua Xu, Kangxin Jin, Zi-Bing Jin
Feng Wang, Ashmita Chander, Yeonsoo Yoon, Mary Wallingford, Carmen Espejo-Serrano, Francisco Bustos, Greg Michael Findlay, Jesse Mager, Ingolf Bach
For the first time, scientists have used CRISPR technology to insert genes that allow immune cells to focus their attack on cancer cells, potentially leaving normal cells unharmed and increasing the effectiveness of immunotherapy.
A new study being presented at this year’s ACAAI Annual Scientific Meeting shows a treatment using the CRISPR genome editing technology succeeded in alleviating swelling and reducing the frequency of attacks.
Un nuevo estudio que se presenta en la Reunión Científica Anual del ACAAI de este año muestra que un tratamiento que usa una tecnología de edición genética de repeticiones palindrómicas cortas, agrupadas y regularmente interespaciadas logró aliviar la inflamación y reducir la frecuencia de los ataques.
Here are some of the latest articles that have been added to the Arthritis channel on Newswise.
Audrey Grain, Jocelyn Ollier, Thierry Guillaume, Patrice Chevallier, Baptiste Le Calvez, Marion Eveillard, Béatrice Clémenceau
Ruolin Zhang, Weibing Mao, Lumeng Niu, Wendai Bao, Yiqi Wang, Zhihao Yang, Yasha Zhu, Haikun Song, Jincao Chen, Guangqiang Li, Meng Cai, Zilong Yuan, Jiawen Dong, Min Zhang,
Ifedolapo Adejumo, Muyiwa Fageyinbo, Precious Obiekwe, Fortune Ibe-Uba, Ibrahim Oreagba, Esther Agbaje
Haruka Wada, Ryo Otsuka, Wilfred Germeraad, Tomoki Murata, Toru Kondo, Ken-Ichiro Seino
Xiaozhen Zhang, Mengyi Lao, HanShen Yang, Kang Sun, Lihong He, Muchun Li, Honggang Ying, Yan Chen, Xueli Bai, Tingbo Liang
Zeynep Karagoz, Fiona Rosaleen Passanha, Lars Robeerst, Martijn van Griensven, Vanessa LaPointe, Aurelie Carlier
Kevin Dzobo, Fatemeh Tavakoli Foroushani
Technology that can change skin tissue into blood vessels and nerve cells also shows promise as a treatment for traumatic muscle loss.
The costliness of drug development and the limitations of studying physiological processes in the lab are two separate scientific issues that may share the same solution.
Xiaojing Liu, Li Liao, Peng Wang, Yuanxin Ye, Xiangyu Dong, Xiaotao Xing, Zhonghan Li, Qiang Wei, Weidong Tian
Xinlin Yang, Wan'an Xiao, Quang Le, Sang-Hyun Lee, Abhijit Dighe, Jason R Kerrigan, Quanjun Cui
Andrej Thurzo, Paulína Gálfiová, Zuzana Varchulová Nováková, Štefan Polák, Ivan Varga, Martin Strunga, Renáta Urban, Jana Surovková, Ľuboš Leško, Zora Hajdúchová, Jozef Feranc, Marian Janek, Ľuboš Danišovič
Yunqi Yao, Lin Zhang, Fuyi Cheng, Qingyuan Jiang, Yixin Ye, Yushuang Ren, Yuting He, Dongsheng Su, Lin Cheng, Gang Shi, Lei Dai, Hongxin Deng
Heather Wojcik, Harold N Lovvorn, Melinda Hollingshead, Janene Pierce, Howard Stotler, Andrew J Murphy, Suzanne Borgel, Hannah M Phelps, Hernan Correa, Alan O Perantoni
Gou Young Koh, Hyuek Jong Lee, Young-Chan Kim, Jungmo Kim, Myung Jin Yang, Seon Pyo Hong, Jueun Lee, Geum-Sook Hwang
Yasuaki Ikuno, Koichiro Watanabe, Yumi Kakeya, Shinsuke Ikeno, Toshimasa Nakabo, Ayano Narumoto, Yukie Kande, Tomoki Hayashi, Kahori Minami, Kasumi Nobuhiro, Yo Mabuchi, Shiho Nakamura, Hideyuki Okano, Dai Ihara,
Marius E. Moeller, Nathaniel V. Mon Pere, Benjamin Werner, Weini Huang
When starved of glucose, yeast kills its own clones and other surrounding microorganisms to survive in a newly discovered phenomenon named latecomer killing.
Johannes Ulrich, Klaus Brehm
Deepti Ramachandran, Nagasuryaprasad Kotikalapudi, David E Maridas, Anton Gulko, Linus T Tsai, Vicki Rosen, Alexander S Banks
Dongdong Jiang, Yongjun Luo, Xiaoshu Wu, Chenyu Huang, Qiaofeng Zhang, Chunzhi Jiang, Qingqiang Yao, Fei Jiang, Pengyu Tang
Karine Rizzoti, Probir Chakravarty, Daniel Sheridan, Robin Lovell-Badge
Yoh Iwasa, Sou Tomimoto, Akiko Satake
Sophie Girardin, Stephan Johannes Ihle, Arianna Menghini, Magdalena Krubner, Leonardo Tognola, Jens Duru, Tobias Ruff, Isabelle Fruh, Matthias Muller, János Vörös
Eldem Sadikoglou, Daniel Domingo-Fernandez, Natalia Savytska, Noemia Fernandes, Patrizia Rizzu, Anastasia Illarionova, Tabea Strauss, Sigrid Schwarz, Alpha Kodamullil, Guenter Hoeglinger, Ashutosh Dhingra, Peter Heutink
Tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases, finds a new study led by UCL researchers.
Alicia Donval, Cinthia Violeta Hernández Puente, Anaïs Lainé, Diana Roman, Romain Vessely, Julien Leclercq, Muriel Perron, Morgane Locker
Alok Maity, Andrew Teschendorff
Zheng Li, Ying Li, Jinling Bai, Zhijiao Wang, Yingying Zhou
M Miletić, N Puač, N Škoro, B Brković, M Andrić, Bb Prokić, V Danilović, S Milutinović-Smiljanić, O Mitrović-Ajtić, S Mojsilović
Amin Namjoynik, Asiful Islam, Mohammad Islam
Ziqi Guo, Shiming Pu, Liu Yang, Yaping Liu, Xin Li, Hongxia Zhao, Zuping Zhou, Cheng Yang
Insulin injections to treat Type 1 diabetes could become a thing of the past, but finding the cure faces many challenges. Although transplanting insulin-producing cells represents a promising approach, this cell therapy requires immunosuppression to prevent rejection. Georgia Tech researchers have developed a new biomaterial called iTOL-100 that could cure Type 1 diabetes by inducing immune acceptance of curative transplanted cells without immunosuppression.
Shimon Slavin
Oier Pastor-Alonso, Irene Dura, Sara Bernardo-Castro, Emilio Varea, Teresa Muro-Garcia, Soraya Martin-Suarez, Juan Manuel Encinas-Perez, Jose Ramon Pineda
Yara Hussein, Utkarsh Tripathi, Ashwani Choudhary, Ritu Nayak, David Peles, Idan Rosh, Jose Djamus, Ronen Spiegel, Tali Garin-Shkolnik, Shani Stern
Menghai Zhu, Chong Lian, Gang Chen, Peng Zou, Beng Gang Qin
Dennis Kruk, Anna Yeung, Alen Faiz, Nick H.T. Ten Hacken, Wim Timens, Toin H. Kuppevelt, Willeke Daamen, Danique Hof, Martin C. Harmsen, Mauricio Rojas, Irene H. Heijink
Mehmet Ali Karaca, Derya Dilek Kancagi, Ugur Ozbek, Ercument Ovali, Ozgul Gok